| ||||||||||||||
|
|
|||||||||||||


*Department of Anesthesia and Intensive Care, IRCCS H "Casa Sollievo della Sofferenza" S. Giovanni Rotondo (FG), Italy;
Department of Anesthesia and Intensive Care, Regina Margherita Childrens Hospital, Turin, Italy; and
Department of Paediatric Anaesthesia and Intensive Care, Astrid Lindgrens Childrens Hospital, Karolinska Hospital, Stockholm, Sweden
Address correspondence and reprint requests to Pasquale De Negri, MD, Department of Anesthesia and Intensive Care, IRCCS H Casa Sollievo della Sofferenza, Viale Cappuccini, 71100 S. Giovanni Rotondo (FG), Italy. Address e-mail to pdenegri{at}libero.it
| Abstract |
|---|
|
|
|---|
Implications: The addition of clonidine (0.080.12µg·kg-1·h-1)to a continuous epidural infusion of ropivacaine was found to improvepostoperative pain relief in children. No clinically significant signs ofsedation or other side effects wereobserved.
| Introduction |
|---|
|
|
|---|
A number of studies have reported the successful clinical use of ropivacaine, a new local anesthetic associated with less risk of systemic toxicity for epidural or caudal blockade in children (57). The pharmacokinetics of this compound in children are similar to those of adults (8,9). Adjuncts to local anesthetics, such as opioids, clonidine, and ketamine, have been administered to further enhance the quality of epidural analgesia (10,11). In previous studies, improved quality, as well as increased duration, of analgesia has been reported when single-bolus injections of clonidine (2 µg/kg) were added to caudally or epidurally administered local anesthetics (12,13). However, the optimal adjunct dose of clonidine for continuous epidural administration in children has not previously been established.
The aim of this study was to identify the dose-response relationship and possible side effects of clonidine when added to a postoperative continuous epidural infusion of ropivacaine in children.
| Methods |
|---|
|
|
|---|
All patients received premedication with oral diazepam 0.4 mg/kg. After application of standard monitoring, general anesthesia was induced by mask with halothane and maintained with isoflurane 0.8%1% in an oxygen/air mixture (fraction of inspired oxygen = 0.5) throughout surgery. The airway was maintained with a laryngeal mask or an orotracheal tube of appropriate size. Neuromuscular block was accomplished with atracurium 0.5 mg/kg when tracheal intubation was performed. After the induction of anesthesia, patients were placed in the lateral position, and under sterile conditions, an epidural catheter was placed at a low lumbar interspace (L5-S1) by using a Tuohy 19-gauge needle. After adequate loss of resistance, the epidural catheter was advanced 3 cm into the epidural space. All blocks were performed by a senior pediatric anesthesiologist.
After the placement of the epidural catheter, the patients received increments of 0.2% ropivacaine for a total dose of 1.4 mg/kg while we watched for signs of toxicity (no test dose was used). The maximum volume injected was 20 mL. The adequacy of the block was tested by pinprick during light anesthesia, as previously described (14,15). Children identified as having an incomplete block were excluded from the study. Sixty minutes after the initial injection of ropivacaine 0.2%, a continuous infusion of plain ropivacaine 0.1% was started at a rate of 0.2 mg · kg-1 · h-1 and was continued for the duration of the surgical procedure.
At the end of surgery, the children were extubated when awake and were transferred to the recovery area. The time from discontinuation of the volatile anesthetic to spontaneous eye opening was noted, and the degree of motor block at awakening was recorded according to a modified Bromage scale (see below). At this point, children were allocated, according to a computer-generated random list, to receive one of four different epidural infusions: plain ropivacaine 0.1% 0.2 mg · kg-1 · h-1 (Group R), ropivacaine 0.08% 0.16 mg · kg-1 · h-1 plus clonidine 0.04 µg · kg-1 · h-1 (1 µg · kg-1 · d-1) (Group RC1), ropivacaine 0.08% 0.16 mg · kg-1 · h-1 plus clonidine 0.08 µg · kg-1 · h-1 (2 µg · kg-1 · d-1) (Group RC2), and ropivacaine 0.08% 0.16 mg · kg-1 · h-1 plus clonidine 0.12 µg · kg-1 · h-1 (3 µg · kg-1 · d-1) (Group RC3); these were infused with an infusion pump (Cadd; Sims Deltec, St. Paul, MN). The infusions were prepared and connected by an operator who took no further part in the study. After a brief observation period in the recovery area, patients were then returned to their regular ward, and the epidural infusion was continued for 48 h.
During the postoperative 48-h period, heart rate, blood pressure, and respiratory rate were measured at arrival in the recovery room and then every 2 h (when patients were awake) by an automatic device. The quality of pain relief was assessed by the Childrens Hospital of Eastern Ontario Pain Score (CHEOPS) (lowest score, 4, no pain; highest score, 13, severe pain) (16). The degree of motor block in the lower extremities was recorded with a modified Bromage scale (0 = no motor block; 1 = inability to raise extended legs; 2 = inability to flex knees; 3 = inability to flex ankle joints) (17), and the degree of sedation was assessed with a three-point sedation scale based on eye opening (0 = eyes open spontaneously; 1 = eyes open to speech; 2 = eyes open in response to physical stimulation) (18). Pain, motor function, and sedation were assessed once in the recovery room (Table 1) and every 4 h if the patient was awake. During the night (11:00 PM to 7:00 AM), evaluations were omitted at least once to allow patients to sleep undisturbed overnight. Additional pain assessments were performed if the child complained of pain. Each child was prescribed acetaminophen/codeine suppositories (200 mg/5 mg, Lonarid; Boehringher, Ingel, Italy) (19) to be given by the nurse if patients had CHEOPS scores >9 on two consecutive assessments 5 min apart. All the assessments of the variables studied were recorded by nurse observers unaware of the mixture used for epidural infusions. The time to first analgesic demand and the total number of postoperative analgesic requests during the 48-h period were noted.
|
Data are presented as means and SD for normally distributed data and as median and range for nonnormally distributed data. The Shapiro-Wilks test was used to assess whether data were normally distributed. If this test did not indicate normal distribution, nonparametric tests were used to assess differences among and within groups. Differences among groups for age, weight, height, and time to spontaneous eye opening at the end of procedure were assessed by the Kruskal-Wallis analysis of variance. Multiple comparisons were performed by Mann-Whitney U-tests with Bonferronis correction. Kruskal-Wallis analysis of variance was performed to assess variations of blood pressure, heart rate, and CHEOPS scores. Sedation scores and motor block were compared with the Mann-Whitney U-test. For all statistical analyses, the significance level was 0.05 and the tests were two tailed.
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
Several recent studies report ropivacaine to be a useful new addition to pediatric regional anesthesia (57). Despite the reduced tendency for motor blockade by ropivacaine compared with bupivacaine, the use of larger concentrations of ropivacaine caused undesired postoperative motor blockade in the lower extremities (22). To avoid unwanted motor blockade and also to reduce the risk of systemic toxicity, ropivacaine 0.1% has been used for postoperative analgesia in children. However, reducing the concentration to 0.1% does not provide clinically reliable postoperative analgesia (23). Use of clonidine as an adjunct to local anesthetics both enhances the quality of pain relief and substantially prolongs the duration of analgesia after caudal and epidural blockade in children (1213). In previous studies, we have determined the pharmacokinetics of epidural clonidine 2 µg/kg in children (24), and we have shown that a caudal bolus injection of ropivacaine 0.1% together with clonidine 2 µg/kg results in better postoperative pain relief than plain ropivacaine 0.2% (25). Despite the well validated effect of clonidine as an adjunct to local anesthetics in pediatric caudal and epidural blockade, no previous data have been available regarding its dosage during continuous postoperative infusions.
Our prospective, observer-blinded, randomized controlled trial provides new information regarding the following three issues. First, our results support previous studies showing suboptimal postoperative analgesia associated with the use of plain ropivacaine 0.1% (23). Second, a clear dose-response for epidurally infused clonidine can be identified with respect to postoperative analgesia. An improved effect with clonidine was observed with respect to CHEOPS scoring and time to first supplemental analgesic request, as well as the total analgesic requirement during the first 48 postoperative hours with increasing doses of clonidine. A dose smaller than 0.08 µg · kg-1 · h-1 was not associated with any measurable effect, whereas dosages
0.08 µg · kg-1 · h-1 produced both clinically and statistically significant improvement in postoperative analgesia. Third, although a slight degree of clonidine-induced postoperative sedation might not be entirely undesirable in children, major sedation could, obviously, be undesirable. A slight trend toward increasing sedation was observed at the largest clonidine dosage in our study. This trend was not statistically significant, but this could potentially be explained by the limited number of patients included in the study. However, further increases in the clonidine dose might be associated with excess sedation (20). Because a dosage of 0.12 µg · kg-1 · h-1 was sufficient to provide excellent analgesia, larger doses may not be advisable as they could result in excessive sedation with no increase in analgesia. The previous reported safety of epidural clonidine administration in children (1213) was further supported by our observations of cardiovascular stability (Table 1) and lack of any significant side effects. Thus, infusions of small concentrations of ropivacaine combined with clonidine are safe and can be used with routine clinical monitoring in healthy ASA physical status I children aged one to four years.
When interpreting the results regarding CHEOPS scores, it should be remembered that larger doses of clonidine produce sedation (20). Sedation is a major confounding factor with the CHEOPS scale (16). However, sedation scores were almost identical between the group not receiving clonidine (Group R) and the three different clonidine groups (Groups RC1, RC2, and RC3)(Fig. 1). The observed similar degree of sedation in all four groups makes any significant inference with CHEOPS scores less likely, in the authors opinion.
We used a low lumbar epidural catheter technique instead of a caudal approach. The appropriateness of caudal catheters for prolonged postoperative use is a matter of discussion with different views. Despite the results published by Kost-Byerly et al. (26), some investigators still maintain that continuous caudal catheters are not appropriate because of the potential risk for bacterial contamination. Therefore, one could speculate that a low lumbar epidural block might not sufficiently block the sacral segments involved in hypospadias repair. If so, the clonidine groups could be at an advantage, because clonidine is thought to act via the dorsal horn, thus making these groups less sensitive to appropriate positioning of the catheter tip. However, adequate postoperative analgesia was present for eight hours in the group receiving ropivacaine only. The authors view this as evidence for appropriate blockade also of the sacral segments with the use of a low lumbar epidural block. This is consistent with our clinical experience and previous results reported from our group using lumbar epidural blocks for this type of surgery (27). However, as has been reported previously (23), an infusion of plain ropivacaine 0.1% is apparently not capable of providing reliable pain relief beyond eight postoperative hours.
In conclusion, epidural coinfusion of clonidine together with ropivacaine 0.08% improves postoperative analgesia compared with plain ropivacaine 0.1%. A clonidine dose of 0.080.12 µg · kg-1 · h-1 appears optimal because smaller doses do not enhance ropivacaine analgesia.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Cucchiaro, S. N. Adzick, J. B. Rose, L. Maxwell, and M. Watcha A comparison of epidural bupivacaine-fentanyl and bupivacaine-clonidine in children undergoing the Nuss procedure. Anesth. Analg., August 1, 2006; 103(2): 322 - 7, table of contents. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Diaz, G. Gouvea, L. Auler, and R. Miecznikowski Thoracic Epidural Anesthesia in Pediatric Liver Transplantation Anesth. Analg., December 1, 2005; 101(6): 1891 - 1892. [Full Text] [PDF] |
||||
![]() |
P.-A. Lonnqvist and N. S. Morton Postoperative analgesia in infants and children Br. J. Anaesth., July 1, 2005; 95(1): 59 - 68. [Full Text] [PDF] |
||||
![]() |
H. T. G. Bergendahl, P. A. Lonnqvist, P. De Negri, G. Ivani, and S. Eksborg Increased Postoperative Arterial Blood Pressure Stability with Continuous Epidural Infusion of Clonidine in Children Anesth. Analg., October 1, 2002; 95(4): 1121 - 1122. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|